A randomised controlled trial with rivaroxaban and apixaban in the treatment for venous thromboembolism in cancer patients
Not Applicable
- Conditions
- Venous thromboembolism with cancer patients
- Registration Number
- JPRN-UMIN000026600
- Lead Sponsor
- Chiba Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
hemorrhage patients Contra-indication to the treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence of venous thromboembolism Hemorrhage
- Secondary Outcome Measures
Name Time Method